CVEvulnerability

CVE-2017-12714

6.5 MEDIUM Published 2018-04-25 Modified 2026-06-17 Official page ↗
Status
Modified
Published
2018-04-25
Last modified
2026-06-17
Assigner
[email protected]
CVSS 3.0 ([email protected])
6.5 MEDIUM — CVSS:3.0/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
CVSS 2.0 ([email protected])
6.1 MEDIUM — AV:A/AC:L/Au:N/C:N/I:N/A:C
Weaknesses
CWE-920

Description

Abbott Laboratories pacemakers manufactured prior to Aug 28, 2017 do not restrict or limit the number of correctly formatted "RF wake-up" commands that can be received, which may allow a nearby attacker to repeatedly send commands to reduce pacemaker battery life. CVSS v3 base score: 5.3, CVSS vector string: AV:A/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:H. Abbott has developed a firmware update to help mitigate the identified vulnerabilities.

Affected configurations

• abbott accent firmware (< f0b.0e.7e) • abbott anthem firmware (< f0b.0e.7e) • abbott accent mri firmware (< f10.08.6c) • abbott accent st firmware (< f10.08.6c) • abbott assurity firmware (< f14.07.80) • abbott allure firmware (< f14.07.80) • abbott assurity mri firmware (< f17.01.49)

Related

Weakness · CWE (1)

  • CWE-920 Improper Restriction of Power Consumption weakness

References